Peripherally Inserted Central Catheter Market Trends and Forecast
The future of the global peripherally inserted central catheter market looks promising with opportunities in the adult and pediatric markets. The global peripherally inserted central catheter market is expected to grow with a CAGR of 4.7% from 2025 to 2031. The major drivers for this market are the increasing cases of chronic diseases, the rising demand for long-term therapies, and the growing use in pediatric care.
• Lucintel forecasts that, within the type category, valve is expected to witness higher growth over the forecast period.
• Within the application category, pediatric is expected to witness higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.
Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.
Emerging Trends in the Peripherally Inserted Central Catheter Market
The peripherally inserted central catheter market is continually evolving, with innovation driven by the need for safer, more effective, and patient-friendly vascular access solutions. Several key trends are emerging that are set to reshape how PICCs are designed, inserted, and utilized in clinical practice, ultimately aiming to improve patient outcomes and reduce healthcare costs.
• Technological Advancements in Catheter Design: Innovations include antimicrobial coatings to reduce infection rates and antithrombogenic properties to prevent blood clots. Power-injectable PICCs are also gaining traction, allowing for high-pressure injections needed in certain imaging procedures. These advancements aim to improve the safety profile and expand the utility of PICCs.
• Increased Use of Ultrasound Guidance: Ultrasound technology for PICC insertion enhances accuracy, reduces the risk of complications like vessel injury, and improves first-attempt success rates. This trend is leading to better patient outcomes and more efficient procedures, becoming a standard of care in many healthcare settings.
• Focus on Nurse-Driven PICC Placement Programs: Expanding the role of trained nurses in PICC insertion can improve efficiency and reduce costs. Standardized training and protocols are crucial for ensuring patient safety and maintaining high-quality care in nurse-led programs.
• Development of Tip-Placement Technologies: Technologies that aid in accurate placement of the catheter tip, such as real-time electromagnetic tracking or electrocardiogram-based systems, are becoming more prevalent. These tools can reduce the need for post-insertion X-rays, saving time and minimizing radiation exposure for patients.
• Growing Adoption in Home Healthcare Settings: As the trend towards home healthcare continues, the demand for PICCs that are easier to manage at home is rising. This includes user-friendly designs and comprehensive patient education to ensure the safe and effective use of PICCs outside of the hospital environment.
These emerging trends are collectively reshaping the PICC market by driving the development and adoption of more sophisticated, safer, and user-friendly catheters and insertion techniques. The emphasis on technology, expanded roles for nurses, and suitability for home care are all contributing to broader utilization of PICCs and improved patient experiences.
Recent Development in the Peripherally Inserted Central Catheter Market
The peripherally inserted central catheter market is characterized by ongoing innovation aimed at improving patient safety and the overall effectiveness of vascular access. Recent key developments reflect a drive towards more sophisticated technologies and techniques in PICC design and utilization.
• Introduction of Antimicrobial Catheters: PICCs with antimicrobial coatings are being developed and adopted to reduce the incidence of catheter-related bloodstream infections. These coatings help inhibit microbial growth on the catheter surface, significantly improving patient safety, especially for those with compromised immune systems.
• Advancements in Insertion Techniques and Guidance Systems: The increased use of ultrasound guidance and the development of tip-placement technologies like electromagnetic navigation are making PICC insertions more accurate and less invasive. This leads to fewer complications and improved patient comfort during the procedure.
• Development of Power-Injectable PICCs: These specialized PICCs are designed to withstand the high pressures of contrast agents used in CT and MRI scans. Their availability expands the utility of PICCs, allowing patients with these lines to undergo necessary imaging without requiring additional vascular access.
• Expansion of PICC Use in Pediatric and Neonatal Care: Modified PICCs with smaller diameters and improved biocompatibility are increasing their application in pediatric and neonatal populations requiring long-term vascular access for medication and nutrition delivery. This reduces the need for more invasive central lines in these vulnerable patients.
• Focus on Materials and Biocompatibility: Research into new catheter materials that are more biocompatible and less prone to causing thrombosis or other complications is ongoing. Hydrophilic materials, for instance, are being explored for their potential to reduce the body's foreign body response.
These developments are significantly impacting the PICC market by making the devices safer, more versatile, and applicable to a broader range of patient populations. The focus on reducing complications and improving the ease and accuracy of insertion is driving greater adoption and better patient outcomes.
Strategic Growth Opportunities in the Peripherally Inserted Central Catheter Market
Strategic growth in the peripherally inserted central catheter market is being fueled by the expanding applications of these devices in various healthcare settings. Identifying and capitalizing on these opportunities can drive market expansion and improve patient care across different medical needs.
• Oncology: The increasing incidence of cancer and the prolonged courses of chemotherapy require reliable and long-term vascular access, making PICCs a preferred choice. Growth opportunities lie in developing PICCs specifically tailored for chemotherapy administration, such as power-injectable and multi-lumen catheters.
• Parenteral Nutrition: Patients requiring long-term nutritional support due to gastrointestinal disorders or other conditions benefit significantly from PICCs. There is a growth opportunity in designing PICCs that are highly compatible with total parenteral nutrition (TPN) solutions and can support prolonged use without complications.
• Antimicrobial Therapy: The rising prevalence of chronic infections requiring extended courses of intravenous antibiotics creates a demand for PICCs. Growth can be achieved by focusing on antimicrobial-coated PICCs that reduce the risk of catheter-related infections in these vulnerable patients.
• Pediatric and Neonatal Care: The need for reliable vascular access in infants and children for medication, fluids, and nutrition is a significant growth area. Developing smaller, more flexible, and biocompatible PICCs tailored to the unique needs of this population presents a key opportunity.
• Home Healthcare: With the increasing trend of patients receiving medical care at home, there is a growing need for PICCs that are easy to manage and maintain in a non-clinical setting. Opportunities exist in developing user-friendly PICCs and providing comprehensive training for patients and caregivers.
These strategic growth opportunities, driven by the specific needs of different patient populations and medical applications, are expanding the scope and utility of PICCs. By focusing on these areas, the market can achieve significant growth while enhancing patient care and outcomes across various healthcare settings.
Peripherally Inserted Central Catheter Market Driver and Challenges
The peripherally inserted central catheter market's trajectory is shaped by various technological, economic, and regulatory factors. These drivers and challenges influence the adoption, innovation, and overall growth of the market, requiring careful consideration by industry players.
The factors responsible for driving the peripherally inserted central catheter market include:
1. Increasing Prevalence of Chronic Diseases: The rising incidence of conditions such as cancer, cardiovascular diseases, and chronic kidney disease necessitates long-term intravenous therapies, thereby driving the demand for PICCs as a reliable vascular access solution. This global trend significantly contributes to market growth.
2. Growing Preference for Minimally Invasive Procedures: PICC insertion is a less invasive procedure compared to traditional central venous catheters, leading to greater acceptance by both healthcare professionals and patients. This preference for minimally invasive techniques fuels the adoption of PICCs.
3. Advancements in Catheter Technology: Continuous innovation in PICC design, including antimicrobial coatings, power injectability, and improved biocompatibility, enhances their safety and utility, driving market growth by offering superior products.
4. Rising Adoption in Home Healthcare: The shift towards home-based medical care increases the demand for PICCs, as they allow for the convenient administration of long-term intravenous treatments outside of hospital settings, improving patient comfort and reducing healthcare costs.
5. Supportive Reimbursement Policies: Favorable reimbursement policies for PICC procedures in many regions encourage their use, making them a more economically viable option for healthcare providers and patients.
Challenges in the peripherally inserted central catheter market are:
1. Risk of Catheter-Related Bloodstream Infections: Despite advancements, the risk of CRBSIs associated with PICCs remains a significant concern. These infections can lead to serious complications, increased hospital stays, and higher healthcare costs, posing a challenge to wider adoption.
2. Occurrence of Deep Vein Thrombosis: PICC placement can sometimes lead to DVT, another serious complication that requires management and can impact patient outcomes. Minimizing this risk through improved insertion techniques and catheter materials is an ongoing challenge.
3. Need for Skilled Professionals: Proper insertion and maintenance of PICCs require trained healthcare professionals. A shortage of such skilled personnel can hinder the widespread and safe adoption of PICC lines, particularly in certain regions.
The interplay of these drivers and challenges significantly impacts the PICC market. While the increasing need for long-term IV access and technological advancements propel growth, the risks of infections and thrombosis, along with the requirement for skilled professionals, necessitate continuous focus on safety and training to ensure the full potential of PICCs is realized.
List of Peripherally Inserted Central Catheter Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies peripherally inserted central catheter companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the peripherally inserted central catheter companies profiled in this report include-
• BD
• Cardinal Health
• AngioDynamics
• Teleflex
• B. Braun
• Vygon
• Spectrum Vascular
• Argon Medical
• Medcomp
• Health Line
Peripherally Inserted Central Catheter Market by Segment
The study includes a forecast for the global peripherally inserted central catheter market by type, application, and region.
Peripherally Inserted Central Catheter Market by Type [Value from 2019 to 2031]:
• Valve Type
• Open-end Type
Peripherally Inserted Central Catheter Market by Application [Value from 2019 to 2031]:
• Adult
• Pediatric
Peripherally Inserted Central Catheter Market by Region [Value from 2019 to 2031]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Country Wise Outlook for the Peripherally Inserted Central Catheter Market
The global peripherally inserted central catheter market is experiencing steady growth, driven by the increasing prevalence of chronic diseases like cancer and the rising need for long-term intravenous therapies. Recent activities across key regions reflect a focus on technological advancements, enhanced safety features, and strategic expansions by major players to meet the evolving demands of healthcare systems. These developments aim to improve patient outcomes and streamline vascular access procedures.
• United States: The US market is marked by the introduction of new devices focused on improving insertion accuracy and reducing complications. For example, Teleflex launched the Arrow® VPS Rhythm® DLX Device in May 2023, which offers real-time catheter tip positioning. Additionally, Cardinal Health is expanding its distribution capabilities with a new center in South Carolina, aiming to enhance the supply chain for medical providers.
• China: China's PICC market is seeing growth due to the increasing prevalence of chronic diseases requiring long-term IV access. There's a focus on improving the quality of PICC maintenance, with recommendations for establishing province-level alliances to standardize guidelines and training for nurses. Major companies are emphasizing innovative insertion technologies to better serve the growing patient population.
• Germany: The European market, including Germany, is witnessing significant growth in PICC adoption for long-term intravenous therapy, driven by the rising prevalence of chronic diseases and the increasing demand for home healthcare. Technological advancements leading to safer catheter materials and designs are also contributing to this expansion. The German intravascular catheter market is generally growing, influenced by a rise in cardiovascular diseases and a focus on minimally invasive procedures.
• India: The Indian central venous catheters market, which includes PICCs, is expanding. Non-antimicrobial central venous catheters currently hold the largest market share. Key players are focusing on providing advanced features. Hospitals remain the primary distribution channel for these devices in India.
• Japan: In Japan, a study highlighted the safe and efficient implementation of PICC insertions by nurse practitioners, particularly for patients with gastroenterological diseases. This suggests a trend towards expanding the roles of nurses in PICC procedures. Major global players also have a presence in the Japanese central venous catheters market.
Features of the Global Peripherally Inserted Central Catheter Market
Market Size Estimates: Peripherally inserted central catheter market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Peripherally inserted central catheter market size by type, application, and region in terms of value ($B).
Regional Analysis: Peripherally inserted central catheter market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the peripherally inserted central catheter market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the peripherally inserted central catheter market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for peripherally inserted central catheter market?
Answer: The global peripherally inserted central catheter market is expected to grow with a CAGR of 4.7% from 2025 to 2031.
Q2. What are the major drivers influencing the growth of the peripherally inserted central catheter market?
Answer: The major drivers for this market are the increasing cases of chronic diseases, the rising demand for long-term therapies, and the growing use in pediatric care.
Q3. What are the major segments for peripherally inserted central catheter market?
Answer: The future of the peripherally inserted central catheter market looks promising with opportunities in the adult and pediatric markets.
Q4. Who are the key peripherally inserted central catheter market companies?
Answer: Some of the key peripherally inserted central catheter companies are as follows:
• BD
• Cardinal Health
• AngioDynamics
• Teleflex
• B. Braun
• Vygon
• Spectrum Vascular
• Argon Medical
• Medcomp
• Health Line
Q5. Which peripherally inserted central catheter market segment will be the largest in future?
Answer: Lucintel forecasts that, within the type category, valve is expected to witness higher growth over the forecast period.
Q6. In peripherally inserted central catheter market, which region is expected to be the largest in next 5 years?
Answer: In terms of region, APAC is expected to witness the highest growth over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the peripherally inserted central catheter market by type (valve type and open-end type), application (adult and pediatric), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Peripherally Inserted Central Catheter Market, Peripherally Inserted Central Catheter Market Size, Peripherally Inserted Central Catheter Market Growth, Peripherally Inserted Central Catheter Market Analysis, Peripherally Inserted Central Catheter Market Report, Peripherally Inserted Central Catheter Market Share, Peripherally Inserted Central Catheter Market Trends, Peripherally Inserted Central Catheter Market Forecast, Peripherally Inserted Central Catheter Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.